Activity of pradofloxacin against Porphyromonas and Prevotella spp. implicated in periodontal disease in dogs: Susceptibility test data from a European Multicenter Study

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 6, 2008, Pages 2149-2155

  Stephan, Bernd ^a   Greife, Heinrich A ^a   Pridmore, Andrew ^b   Silley, Peter ^c,d  

^a BAYER PHARMA AG   (Germany)

^b Don Whitley Scientific Limited   (United Kingdom)

^c MB Consult Limited   (United Kingdom)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ENROFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PRADOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DOG; EUROPE; MINIMUM INHIBITORY CONCENTRATION; PERIODONTAL DISEASE; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEROIDACEAE INFECTIONS; DOG DISEASES; DOGS; EUROPE; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; PERIODONTAL DISEASES; PORPHYROMONAS; PREVOTELLA;

EID: 44449124540     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00019-08     Document Type: Article

References (47)

1. Ackermann, G., R. Schaumann, B. Pless, M. C. Claros, E. J. C. Goldstein, and A. C. Rodloff. 2000. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 19:228-232.
2. Aldridge, K. E., and D. S. Ashcraft. 1997. Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes. Antimicrob. Agents Chemother. 41:709-711.
3. Ali, R. W., G. Bancescu, Ø. Nielsen, and N. Skaug. 1995. Viability of four putative periodontal pathogens and enteric rods in the anaerobic transport medium VMGA III. Oral Microbiol. Immunol. 10:365-371.
4. Bell, A. F. 1967. Dental disease in the dog. J. Small Anim. Pract. 6:421-428.
5. Black, A. P., A. M. Crichlow, and J. R. Saunders. 1980. Bacteraemia during ultrasonic teeth cleaning and extraction in the dog. J. Am. Anim. Hosp. Assoc. 16:611-616.
6. Colmery, B., and P. Frost. 1986. Periodontal disease. Etiology and pathogenesis. Vet. Clin. North Am. Small Anim. Pract. 16:817-833.
7. Cutler, C. W., J. R. Kulmar, and C. A. Genco. 1995. Pathogenic strategies of the oral anaerobe Porphyromonas gingivalis. Trends Microbiol. 3:45-50.
8. Dahlén, G., P. Pipattanagovit, B. Rosling, and A. J. R. Møller. 1993. A comparison of two transport media for saliva and subgingival samples. Oral Microbiol. Immunol. 8:377-382.
9. DeBowes, L. J., D. Mosier, E. Logan, C. E. Harvey, S. Lowry, and D. C. Richardson. 1996. Association of periodontal disease and histologic lesions in multiple organs from 45 dogs. J. Vet. Dent. 13:57-60.
10. Eisenberg, L., R. Suchow, R. S. Coles, and M. J. Deasy. 1991. The effects of metronidazole administration on clinical and microbiologic parameters of periodontal disease. Clin. Prev. Dent. 12:28-34.
11. Fournier, D., C. Mouton, P. Lapierre, T. Kato, K. Okuda, and C. Ménard. 2001. Porphyromonas gulae sp. nov., an anerobic, Gram-negative coccobacillus from the gingival sulcus of various animal hosts. Int. J. Syst. Evol. Microbiol. 51:1179-1189.
12. Gad, T. 1968. Periodontal diseases in dogs. J. Periodontal Res. 3:268-272.
13. Golden, A. L., N. Stoller, and C. E. Harvey. 1982. Survey of oral and dental diseases in dogs anaesthetized at a veterinary hospital. J. Am. Anim. Hosp. Assoc. 18:891-899.
14. Goldstein, E. J. C. 1996. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety. Clin. Infect. Dis. 23(Suppl. 1):S25-S30.
15. Goldstein, E. J. C. 2000. Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens. J. Antimicrob. Chemother. 45(Suppl. 1):55-65.
16. Hamp, S. E., K. Olsson, K. Farsø-Madsen, P. Viklands, and J. Fornell. 1984. A microscopic and radiologic investigation of dental diseases of the dog. Vet. Radiol. 25:86-92.
17. Hardham, J., K. Dreier, J. Wong, C. Sfintescu, and R. T Evans. 2005. Pigmented-anaerobic bacteria associated with canine periodontitis. Vet. Microbiol. 106:119-128.
18. Harvey, C. E. 1998. Periodontal disease in dogs. Etiopathogenesis, prevalence, and significance. Vet. Clin. N. Am. Small Anim. Pract. 28:1111-1128.
19. Harvey, C. E., and P. P. Emily. 1993. Small animal dentistry, p.104. Mosby-Year Books, St. Louis, MO.
20. Harvey, C. E., F. S. Shofer, and L. Laster. 1994. Association of age and body weight with periodontal disease in North American dogs. J. Vet. Dent. 13:101-105.
21. Harvey, C. E., C. Thornsberry, and B. R. Miller. 1995. Subgingival bacteria - comparison of culture results in dogs and cats with gingivitis. J. Vet. Dent. 12:147-150.
22. Hennet, P. R. 1995. Periodontal disease and oral microbiology, p. 105-113. In D. A. Crossley and S. Penman (ed.), BSAVA manual of small animal dentistry. British Small Animal Veterinary Association, Cheltenham, United Kingdom.
23. Hennet, P. R., and C. E. Harvey. 1991. Aerobes in periodontal disease in the dog: a review. J. Vet. Dent. 8:9-11.
24. Hirsh, D. C. 2000. Selected bacterial infections: anaerobes, p. 458-460. In J. F. Prescott, J. D. Baggot, and R. D. Walker (ed.), Antimicrobial therapy in veterinary medicine. Iowa State University Press, Ames, IA.
25. Isogai, H., Y. Kosako, Y. Benno, and E. Isogai. 1999. Ecology of genus Porphyromonas in canine periodontal disease. J. Vet. Med. 46:467-473.
26. King, A., J. Downes, C. E. Nord, and I. Phillips. 1999. Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe. Clin. Microbiol. Infect. 5:404-416.
27. Lamont, R. J., and H. F. Jenkinson. 1998. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis in canine periodontal disease. Microbiol. Mol. Biol. Rev. 62:1244-1263.
28. Loesche, W. J., and N. S. Grossman. 2001. Periodontal disease as a specific albeit chronic infection: diagnosis and treatment. Clin. Microbiol. Rev. 14:727-732.
29. Milazzo, I., G. Blandino, R. Musumeci, G. Nicoletti, A. M. Lo Bue, and A. Speciale. 2002. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int. J. Antimicrob. Agents 20:451-456.
30. Miller, B. R., and C. E. Harvey. 1994. Compliance with oral hygiene recommendations following periodontal treatment in client-owned dogs. J. Vet. Dent. 11:18-19.
31. Nielsen, D., C. Walser, G. K. Kodan. R. D. Chaney, T. Yonkers, J. D. VerSteeg, G. Elfring, and J. Slots. 2000. Effects of treatment with clindamycin hydrochloride on progression of canine periodontal disease after ultrasonic scaling. Vet. Ther. 1:150-158.
32. Nieves, M. A., P. Hartwig, J. M. Kinyon, and D. H. Riedesel. 1997. Bacterial isolates from plaque and from blood during and after routine dental procedures in dogs. Vet. Surg. 26:26-32.
33. Okuda, K., T. Kato, and K. Ishihara. 2004. Involvement of periodontopathic biofilm in vascular diseases. Oral Dis. 10:5-12.
34. Page, R. C. 2000. Vaccination and periodontitis: myth or reality. J. Int. Acad. Periodontol. 2:31-43.
35. Page, R. C., and L. S. Houston. 1999. Prospects for vaccination against plaque-related oral diseases, p. 563-585. In H. N. Newman and M. Wilson (ed.), Dental plaque revisited: oral biofilms in health and disease. BioLine, Cardiff, United Kingdom.
36. Pattison, A. M. 1996. The use of hand instruments in supportive periodontal treatment. Periodontol. 2000 12:71-89.
37. Pfister, W., S. Eick, and S. Assefa. 2001. Activity of quinolones to oral anaerobic and capnophilic bacteria. Int. J. Med. Microbiol. 291(Suppl. 32):72.
38. Rodenburg, J. P., A. J. Van Winkelhoff, E. G. Winkel, R. J. Goené, F. Abbas, and J. Graff. 1990. Occurrence of Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in severe periodontitis in relation to age and treatment history. J. Clin. Periodontol. 17:392-399.
39. Scannapieco, F. A., R. B. Bush, and S. Paju. 2003. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann. Periodontol. 8:54-69.
40. Silley, P., B. Stephan, H. A. Greife, and A. Pridmore. 2007. Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats. J. Antimicrob. Chemother. 60:999-1003.
41. Slots, J., and M. G. Jorgensen. 2002. Effective, safe, practical and affordable periodontal antimicrobial therapy: where are we going, and are we there yet? Periodontol. 2000 28:298-312.
42. Slots, J., and T. E. Rams. 1990. Antibiotics in periodontal therapy: advantages and disadvantages. J. Clin. Periodontol. 17:479-493.
43. Slots, J., and M. Ting. 2002. Systemic antibiotics in the treatment of periodontal disease. Periodontol. 2000 28:106-176.
44. Stambaugh, R. V., M. Dragoo, D. M. Smith, and L. Carasali. 1981. The limits of subgingival scaling. Int. J. Periodontics Restorative Dent. 1:30-41.
45. Stephan, B., S. Friederichs, A. Pridmore, O. Roy, M. Edingloh, and H. A. Greife. 2006. Novel fluoroquinolone pradofloxacin: clinical efficacy and safety in the treatment of feline wound infections. J. Vet. Pharmacol. Ther. 29(Suppl. 1):77-78.
46. Van Steenbergen, T. J. M., M. D. A. Petit, C. J. Tijhof, A. J. van Winkelhoff, U. van der Velden, and J. De Graaff. 1993. Survival in transport media of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia in human subgingival samples. Oral Microbiol. Immunol. 8:370-374.
47. Zetner, K., and G. Thiemann. 1993. The antimicrobial effectiveness of clindamycin in diseases of the oral cavity. J. Vet. Dent. 10:6-9.